The installation at Huntsman Cancer Institute, which is ranked consistently by U.S. News & World Report as one of the top cancer hospitals in the United States, will feature a 1.5 Tesla magnetic resonance (”MR”) scanner as part of a fully integrated imaging suite.
IMRISneuro provides timely, high resolution MR images to the medical team before, during and after an operation without moving the patient from the surgical table. The wide bore MR scanner will move between an operating theatre and a diagnostic facility, providing state-of-the-art, multi-functional capabilities to the hospital’s neuroscience facility.
No other system offers the same degree of safety for both the patient and the surgical environment. IMRISneuro does not require the patient to be transported for scanning, so the optimum position for neurosurgery is never compromised. Clinical workflow and surgical access to the patient is not impacted and the magnet is removed completely from the operating room when scanning is complete. The IMRISneuro system provides neurosurgeons with timely images during surgery from which they are able to make better decisions for their patients.
About IMRIS
IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced imaging solutions that incorporate multiple imaging modalities including magnetic resonance and fluoroscopy to deliver timely information to clinicians during surgical or interventional procedures. The Company’s systems serve the neurosurgical, cardiovascular and neurovascular markets and utilize patented technology that allows a high field MR scanner to be moved in to the operating room on demand, providing imaging during surgical or interventional procedures without compromising patient safety. The Company’s products have been selected by leading medical facilities around the world.
About Huntsman Cancer Institute at the University of Utah
Huntsman Cancer Institute (HCI) at the University of Utah marks its 10th anniversary in 2009. HCI was founded by Jon M. Huntsman to fulfill his dream of finding a cure for cancer through genetic research. In the last 10 years, HCI has grown to become one of America’s major cancer research centers. HCI is part of the University of Utah healthcare system and is ranked consistently by U.S. News & World Report as one of the top cancer hospitals in the country.
For further information: Brad Woods, Director Investor Relations & Corporate Communications, IMRIS Inc., Tel: (204) 480-7094, Email: bwoods@imris.com
taken from:
0 comments: on "Huntsman Cancer Institute purchases IMRISneuro"
Post a Comment